Ing. J. Peter BSc

Laboratory technician
Main activities
Patient care, Research, Teaching
DNA, NGS, Sequencing, HDL, LDL
Focus of research

To identify novel genes in families in which a strong autosomal dominant trait for extreme lipid disorders or premature atherosclerosis of unknown aetiology is observed.

Key publications
  • Cunha MLR , Bakhtiari K, Peter J, Marquart JA, Meijers JCM, Middeldorp S, A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function. BLOOD 2015;125 (11):1822-1825 [PubMed]
  • Motazacker MM, Pirruccello J, Huijgen R, Do R, Gabriel S, Peter J, Kuivenhoven JA, Defesche JC, Kastelein JJP, Hovingh GK, Zelcer N, Kathiresan S, Fouchier SW, Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia. EUR HEART J 2012;33 (11):1360-1366 [PubMed]
  • Surendran RP, Visser ME, Heemelaar S, Wang J, Peter J, Defesche JC, Kuivenhoven JA, Hosseini M, Péterfy M, Kastelein JJP, Johansen CT, Hegele RA, Stroes ESG, Dallinga-Thie GM, Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. J INTERN MED 2012;272 (2):185-196 [PubMed]
  • Holleboom AG, Kuivenhoven JA, Peelman F, Schimmel AW, Peter J, Defesche JC, Kastelein JJP, Hovingh GK, Stroes ES, Motazacker MM, High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations. HUM MUTAT 2011;32 (11):1290-1298 [PubMed]
  • Beigneux AP, Franssen R, Bensadoun A, Gin P, Melford K, Peter J, Walzem RL, Weinstein MM, Davies BSJ, Kuivenhoven JA, Kastelein JJP, Fong LG, Dallinga-Thie GM, Young SG, Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein Lipase. ARTERIOSCL THROM VAS 2009;29 (6):956-U447 [PubMed]
All Publications
Research programmes

Prof. dr. J.C.M. Meijers (Biochemistry of hemostasis and thrombosis)